Search research articles
Contact Us
Filters
Showing results (511-520 of 541) with videos related to
Page
of 55
Sort By:
Biomed Research International
|
July 19, 2013
Kidney dosimetry in ¹⁷⁷Lu and ⁹⁰Y peptide receptor radionuclide therapy: influence of image timing, time-activity integration method, and risk factors
F Guerriero, M E Ferrari, F Botta, et al.
Lancet (London, England)
|
June 24, 2000
Paternal concentrations of dioxin and sex ratio of offspring
P Mocarelli, P M Gerthoux, E Ferrari, et al.
Basic & Clinical Pharmacology & Toxicology
|
March 24, 2011
Preclinical pharmacology and safety of a novel avidin derivative for tissue-targeted delivery of radiolabelled biotin
Fiorella Petronzelli, Anna M Anastasi, Angela Pelliccia, et al.
Pediatrics
|
November 6, 2001
Botulinum toxin type a neuromuscular blockade in the treatment of equinus foot deformity in cerebral palsy: a multicenter, open-label clinical trial
L A Koman, A Brashear, S Rosenfeld, et al.
Scientific Reports
|
August 29, 2015
Single Shot Polarization Characterization of XUV FEL Pulses from Crossed Polarized Undulators
E Ferrari, E Allaria, J Buck, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 10, 1999
Phase II study of cisplatin and vinorelbine as first-line chemotherapy in patients with carcinoma of the uterine cervix
S Pignata, G Silvestro, E Ferrari, et al.
Oncology
|
May 27, 1999
A phase I study of paclitaxel and epirubicin, without and with filgrastim, for the treatment of platinum-resistant advanced ovarian cancer
R Lauria, E Ferrari, S Tramontana, et al.
Oncogene
|
November 7, 2012
Novel BRD4-NUT fusion isoforms increase the pathogenic complexity in NUT midline carcinoma
K Thompson-Wicking, R W Francis, A Stirnweiss, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
September 18, 2009
Intraoperative avidination for radionuclide treatment as a radiotherapy boost in breast cancer: results of a phase II study with (90)Y-labeled biotin
Giovanni Paganelli, Concetta De Cicco, Mahila E Ferrari, et al.
Ecancermedicalscience
|
January 26, 2012
IART (Intra-Operative Avidination for Radionuclide Therapy) for accelerated radiotherapy in breast cancer patients. Technical aspects and preliminary results of a phase II study with 90Y-labelled biotin
G Paganelli, C De Cicco, M E Ferrari, et al.
Page
of 55
Search research articles
Search
Showing results (511-520 of 541) with videos related to
Sort By:
Page
of 55
Biomed Research International
|
July 19, 2013
Kidney dosimetry in ¹⁷⁷Lu and ⁹⁰Y peptide receptor radionuclide therapy: influence of image timing, time-activity integration method, and risk factors
F Guerriero, M E Ferrari, F Botta, et al.
Lancet (London, England)
|
June 24, 2000
Paternal concentrations of dioxin and sex ratio of offspring
P Mocarelli, P M Gerthoux, E Ferrari, et al.
Basic & Clinical Pharmacology & Toxicology
|
March 24, 2011
Preclinical pharmacology and safety of a novel avidin derivative for tissue-targeted delivery of radiolabelled biotin
Fiorella Petronzelli, Anna M Anastasi, Angela Pelliccia, et al.
Pediatrics
|
November 6, 2001
Botulinum toxin type a neuromuscular blockade in the treatment of equinus foot deformity in cerebral palsy: a multicenter, open-label clinical trial
L A Koman, A Brashear, S Rosenfeld, et al.
Scientific Reports
|
August 29, 2015
Single Shot Polarization Characterization of XUV FEL Pulses from Crossed Polarized Undulators
E Ferrari, E Allaria, J Buck, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 10, 1999
Phase II study of cisplatin and vinorelbine as first-line chemotherapy in patients with carcinoma of the uterine cervix
S Pignata, G Silvestro, E Ferrari, et al.
Oncology
|
May 27, 1999
A phase I study of paclitaxel and epirubicin, without and with filgrastim, for the treatment of platinum-resistant advanced ovarian cancer
R Lauria, E Ferrari, S Tramontana, et al.
Oncogene
|
November 7, 2012
Novel BRD4-NUT fusion isoforms increase the pathogenic complexity in NUT midline carcinoma
K Thompson-Wicking, R W Francis, A Stirnweiss, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
September 18, 2009
Intraoperative avidination for radionuclide treatment as a radiotherapy boost in breast cancer: results of a phase II study with (90)Y-labeled biotin
Giovanni Paganelli, Concetta De Cicco, Mahila E Ferrari, et al.
Ecancermedicalscience
|
January 26, 2012
IART (Intra-Operative Avidination for Radionuclide Therapy) for accelerated radiotherapy in breast cancer patients. Technical aspects and preliminary results of a phase II study with 90Y-labelled biotin
G Paganelli, C De Cicco, M E Ferrari, et al.
Page
of 55